Vanda Pharmaceuticals (VNDA) Amortization - Intangibles (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Amortization - Intangibles of $2.0 million for Q1 2026, up 13.41% on a YoY basis from $1.8 million in Q1 2025, and up 16.4% sequentially from $1.7 million in Q4 2025.
Vanda Pharmaceuticals (VNDA) Amortization - Intangibles (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Amortization - Intangibles data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 13.41% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 2.4% YoY), and the FY2025 full-year result was $7.0 million, down 3.66% from the prior year.
- Amortization - Intangibles rose to $2.0 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $2.0 million in Q1 2024 to a low of $379000.0 in Q4 2022.
- A 5-year average of $1.2 million and a median of $1.7 million in 2025 frame the typical range for Amortization - Intangibles.
- Across the five-year window, Amortization - Intangibles soared 400.0% in 2024 and slipped 12.4% in 2025, its largest moves.
- Tracing VNDA's Amortization - Intangibles over 5 years: stood at $379000.0 in 2022, then soared by 161.21% to $990000.0 in 2023, then jumped by 79.09% to $1.8 million in 2024, then slipped by 3.72% to $1.7 million in 2025, then advanced by 16.4% to $2.0 million in 2026.
- Business Quant data shows VNDA's Amortization - Intangibles at $2.0 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 990,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 400,000.00 |
| Dec 31, 2022 | 379,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 378,000.00 |
| Sep 30, 2021 | 370,000.00 |
| Jun 30, 2021 | 400,000.00 |